Title : Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression.

Pub. Date : 2011 May 20

PMID : 21454520






10 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression. Arsenic tumor protein p53 Homo sapiens
2 Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression. Arsenic tumor protein p53 Homo sapiens
3 Interestingly, wild type p53 is accumulated in cells treated with arsenic compounds, presumably due to arsenic-induced oxidative stresses. Arsenic tumor protein p53 Homo sapiens
4 Interestingly, wild type p53 is accumulated in cells treated with arsenic compounds, presumably due to arsenic-induced oxidative stresses. Arsenic tumor protein p53 Homo sapiens
5 In contrast, we found that arsenic compounds degrade both endogenous and ectopically expressed mutant p53 in time- and dose-dependent manners. Arsenic tumor protein p53 Homo sapiens
6 We also found that arsenic trioxide decreases the stability of mutant p53 protein through a proteasomal pathway, and blockage of mutant p53 nuclear export can alleviate the arsenic-induced mutant p53 degradation. Arsenic tumor protein p53 Homo sapiens
7 Taken together, we found that mutant p53 is a target of arsenic compounds, which provides an insight into exploring arsenic compound-based therapy for tumors harboring a mutant p53. Arsenic tumor protein p53 Homo sapiens
8 Taken together, we found that mutant p53 is a target of arsenic compounds, which provides an insight into exploring arsenic compound-based therapy for tumors harboring a mutant p53. Arsenic tumor protein p53 Homo sapiens
9 Taken together, we found that mutant p53 is a target of arsenic compounds, which provides an insight into exploring arsenic compound-based therapy for tumors harboring a mutant p53. Arsenic tumor protein p53 Homo sapiens
10 Taken together, we found that mutant p53 is a target of arsenic compounds, which provides an insight into exploring arsenic compound-based therapy for tumors harboring a mutant p53. Arsenic tumor protein p53 Homo sapiens